Mupirocin and Modafinil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mupirocin (mupirocin) and Modafinil (modafinil). Common drug interactions include flushing among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Mupirocin and Modafinil. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Mupirocin?

Mupirocin has active ingredients of mupirocin. It is often used in impetigo. eHealthMe is studying from 5,940 Mupirocin users. Check the latest studies of Mupirocin.

What is Modafinil?

Modafinil has active ingredients of modafinil. It is often used in narcolepsy. eHealthMe is studying from 20,805 Modafinil users. Check the latest studies of Modafinil.



On Jul, 13, 2026

38 people who take Mupirocin and Modafinil together, and have interactions are studied.

Mupirocin and Modafinil drug interactions.

What are the common drug interactions of Mupirocin and Modafinil, by gender? *:

female:

  1. Flushing (the warm, red condition of human skin)
  2. Foot fracture
  3. Heart rate decreased
  4. Heparin-induced thrombocytopenia
  5. Hepatic enzyme increased
  6. Hepatic failure (liver failure)
  7. Hepatic steatosis (fatty liver disease)
  8. Hunger
  9. Hypertension (high blood pressure)
  10. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Hand fracture
  4. Sensory loss (senses loss)
  5. Spinal stenosis (narrowing of spinal column)
  6. Hospitalisation
  7. Abdominal discomfort
  8. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  9. Blood pressure increased
  10. Bubonic plague (bubonic plague: an infectious disease that is caused by the bacterium yesinia pestis)

What are the common drug interactions of Mupirocin and Modafinil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Muscle spasms (muscle contraction)
  2. Abdominal discomfort
  3. Chest pain
  4. Depression
  5. Dyspnoea (difficult or laboured respiration)
  6. Epistaxis (bleed from the nose)
  7. Eye discharge
  8. Hypersensitivity
  9. Injection site bruising

40-49:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Precancerous cells present
  3. Skin cancer
  4. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  5. Adverse event
  6. Asthenia (weakness)
  7. Cardiac disorder
  8. Chest pain
  9. Chronic kidney disease
  10. Contusion (a type of hematoma of tissue in which capillaries)

50-59:

  1. Abdominal discomfort
  2. Abdominal distension
  3. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  4. Arthropathy
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Flushing (the warm, red condition of human skin)
  7. Hepatic steatosis (fatty liver disease)
  8. Irritable bowel syndrome
  9. Postoperative wound infection
  10. Pruritus (severe itching of the skin)

60+:

  1. Arthralgia (joint pain)
  2. Back injury
  3. Nausea (feeling of having an urge to vomit)
  4. Oxygen saturation decreased
  5. Pneumonia
  6. Pruritus (severe itching of the skin)
  7. Rash erythematous (redness of the skin)
  8. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  9. Weight decreased
  10. Back pain

What are the existing conditions these people have? *

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 14 people, 36.84%
  2. Drowsiness: 8 people, 21.05%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 15.79%
  4. Pain: 5 people, 13.16%
  5. Stress And Anxiety: 3 people, 7.89%
  6. High Blood Cholesterol: 3 people, 7.89%
  7. Asthma: 3 people, 7.89%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 7.89%
  9. Hiv Infection: 3 people, 7.89%
  10. Nausea (feeling of having an urge to vomit): 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Mupirocin and Modafinil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mupirocin and Modafinil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mupirocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Modafinil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mupirocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Modafinil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mupirocin and modafinil (the active ingredients of Mupirocin and Modafinil, respectively), and Mupirocin and Modafinil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: